| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bukwang Pharm (KO: 003000)
003000 Technical Analysis
5
| As on 25th Feb 2026 003000 STOCK Price closed @ 5360.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4045.19 & Strong Buy for SHORT-TERM with Stoploss of 4744.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
003000STOCK Price
| Open | 5980.00 | Change | Price | % |
| High | 6000.00 | 1 Day | -510.00 | -8.69 |
| Low | 5300.00 | 1 Week | 1035.00 | 23.93 |
| Close | 5360.00 | 1 Month | 1690.00 | 46.05 |
| Volume | 4685029 | 1 Year | 500.00 | 10.29 |
| 52 Week High 5870.00 | 52 Week Low 3225.00 | ||||
KO Korea Most Active Stocks
| 004410 | 268.00 | 15.52% |
| 004410 | 268.00 | 15.52% |
| 093230 | 33.00 | -49.23% |
| 093230 | 33.00 | -49.23% |
| 007460 | 462.00 | -15.38% |
| 007460 | 462.00 | -15.38% |
| 004060 | 704.00 | 3.07% |
| 004060 | 704.00 | 3.07% |
| 092220 | 1190.00 | 15.76% |
| 092220 | 1190.00 | 15.76% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
| 003000 Daily Charts |
003000 Intraday Charts |
Whats New @ Bazaartrend |
003000 Free Analysis |
|
|
003000 Important Levels Intraday
| RESISTANCE | 6708.90 |
| RESISTANCE | 6276.30 |
| RESISTANCE | 6008.90 |
| RESISTANCE | 5741.50 |
| SUPPORT | 4978.50 |
| SUPPORT | 4711.10 |
| SUPPORT | 4443.70 |
| SUPPORT | 4011.10 |
003000 Forecast February 2026
| 4th UP Forecast | 6564.38 |
| 3rd UP Forecast | 6178.13 |
| 2nd UP Forecast | 5939.38 |
| 1st UP Forecast | 5700.63 |
| 1st DOWN Forecast | 5019.38 |
| 2nd DOWN Forecast | 4780.63 |
| 3rd DOWN Forecast | 4541.88 |
| 4th DOWN Forecast | 4155.63 |
003000 Weekly Forecast
| 4th UP Forecast | 6689.63 |
| 3rd UP Forecast | 6263.21 |
| 2nd UP Forecast | 5999.63 |
| 1st UP Forecast | 5736.05 |
| 1st DOWN Forecast | 4983.95 |
| 2nd DOWN Forecast | 4720.37 |
| 3rd DOWN Forecast | 4456.79 |
| 4th DOWN Forecast | 4030.37 |
003000 Forecast2026
| 4th UP Forecast | 11237.3 |
| 3rd UP Forecast | 9352.45 |
| 2nd UP Forecast | 8187.35 |
| 1st UP Forecast | 7022.25 |
| 1st DOWN Forecast | 3697.75 |
| 2nd DOWN Forecast | 2532.65 |
| 3rd DOWN Forecast | 1367.55 |
| 4th DOWN Forecast | -517.35 |
Bukwang Pharm ( KO Korea Symbol : 003000 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
003000 Business Profile
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea. Address: 7, Sangdo-ro, Seoul, South Korea, 06955
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service